LIPOSYN III 10% Drug Patent Profile
Which patents cover Liposyn Iii 10%, and when can generic versions of Liposyn Iii 10% launch?
Liposyn Iii 10% is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in LIPOSYN III 10% is soybean oil. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LIPOSYN III 10%?
- What are the global sales for LIPOSYN III 10%?
- What is Average Wholesale Price for LIPOSYN III 10%?
Summary for LIPOSYN III 10%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 4 |
| DailyMed Link: | LIPOSYN III 10% at DailyMed |
Recent Clinical Trials for LIPOSYN III 10%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Cleveland Clinic | Early Phase 1 |
| Pennington Biomedical Research Center | Early Phase 1 |
| The University of Texas Health Science Center at San Antonio | N/A |
US Patents and Regulatory Information for LIPOSYN III 10%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | LIPOSYN III 10% | soybean oil | INJECTABLE;INJECTION | 018969-001 | Sep 24, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
